Resonant Capital Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$956K Sell
2,404
-3
-0.1% -$1.31K 0.05% 191
2026
Q1
$1.11M Sell
2,407
-49
-2% -$24.8K 0.06% 167
2025
Q4
$1.39M Buy
2,456
+978
+66% +$521K 0.08% 146
2025
Q3
$661K Sell
1,478
-338
-19% -$162K 0.04% 210
2025
Q2
$987K Buy
1,816
+262
+17% +$137K 0.06% 160
2025
Q1
$770K Buy
1,554
+22
+1% +$12.2K 0.05% 167
2024
Q4
$800K Buy
1,532
+6
+0.4% +$3.13K 0.06% 164
2024
Q3
$750K Buy
1,526
+119
+8% +$55.4K 0.06% 174
2024
Q2
$626K Sell
1,407
-95
-6% -$37.8K 0.05% 182
2024
Q1
$599K Buy
1,502
+447
+42% +$169K 0.05% 181
2023
Q4
$356K Buy
1,055
+19
+2% +$5.66K 0.03% 209
2023
Q3
$303K Sell
1,036
-12
-1% -$3.75K 0.03% 213
2023
Q2
$358K Buy
1,048
+44
+4% +$13.3K 0.04% 188
2023
Q1
$256K Sell
1,004
-29
-3% -$7.14K 0.03% 221
2022
Q4
$274K Buy
+1,033
New +$252K 0.03% 221

Other funds holding ISRG

Resonant Capital Advisors's ISRG Position: Q2 2026 in Review

Resonant Capital Advisors reduced its Intuitive Surgical (ISRG) stake by 0.12% in Q2 2026, selling an estimated $1.31K and leaving 2,404 shares worth $956K. The position accounts for 0.05% of the portfolio, ranked #191.

Resonant Capital Advisors first reported a position in ISRG in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.39M in Q4 2025. 1,081 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Resonant Capital Advisors held 2,404 shares of Intuitive Surgical worth $956K as of Q2 2026.
  • Resonant Capital Advisors sold 3 Intuitive Surgical shares in Q2 2026, an estimated $1.31K.
  • Intuitive Surgical made up 0.05% of Resonant Capital Advisors's portfolio in Q2 2026, its #191 holding.
  • Resonant Capital Advisors first reported a position in Intuitive Surgical in Q4 2022 and has held it in 15 quarters since.
  • Resonant Capital Advisors's Intuitive Surgical position peaked at $1.39M in Q4 2025.
  • 1,081 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.